FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $815,202 | -43.9% | 171,261 | -32.8% | 0.04% | -51.1% |
| Q1 2023 | $1,453,437 | +1187.2% | 254,989 | +2178.5% | 0.09% | +1185.7% |
| Q4 2022 | $112,917 | -54.1% | 11,191 | +2.1% | 0.01% | -61.1% |
| Q3 2022 | $246,000 | -10.9% | 10,962 | -1.7% | 0.02% | 0.0% |
| Q2 2022 | $276,000 | -43.1% | 11,154 | -10.8% | 0.02% | -10.0% |
| Q1 2022 | $485,000 | -40.4% | 12,511 | -10.1% | 0.02% | -25.9% |
| Q4 2021 | $814,000 | -11.3% | 13,911 | -10.2% | 0.03% | -12.9% |
| Q3 2021 | $918,000 | +350.0% | 15,495 | +558.2% | 0.03% | +342.9% |
| Q2 2021 | $204,000 | – | 2,354 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |